Chern Ein Oon
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Geriatrics and Gerontology top 5%
Papers in
-
- Histone Deacetylase Inhibitors Research 7
- Gut microbiota and health 6
- Angiogenesis and VEGF in Cancer 6
-
- Bioactive Compounds in Plants 7
- Co-authors
- Yi Jer Tan (9 shared papers)Yeuan Ting Lee (9 shared papers)Adrian L. Harris (6 shared papers)Gurjeet Kaur (9 shared papers)Amin Malik Shah Abdul Majid (18 shared papers)Venugopal Balakrishnan (7 shared papers)Jiliang Li (3 shared papers)Helen Turley (4 shared papers)
- Journals
- Life Sciences (4 papers)Biomedicine & Pharmacotherapy (3 papers)European Journal of Pharmacology (2 papers)Microvascular Research (2 papers)Drug and Chemical Toxicology (2 papers)
- Partner nations
- MalaysiaAustraliaUnited Kingdom
In The Last Decade
Chern Ein Oon
67 papers receiving 2.8k citations
Chern Ein Oon's Hit Papers
Peers
Comparison fields: 5 of 127
- Cancer Research 583
- Geriatrics and Gerontology 80
- Molecular Biology 1.4k
- Oncology 473
- Applied Microbiology and Biotechnology 27
Countries citing papers authored by Chern Ein Oon
This map shows the geographic impact of Chern Ein Oon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chern Ein Oon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chern Ein Oon more than expected).
Fields of papers citing papers by Chern Ein Oon
This network shows the impact of papers produced by Chern Ein Oon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chern Ein Oon. The network helps show where Chern Ein Oon may publish in the future.
Co-authors
The 25 scholars most cited alongside Chern Ein Oon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Molecular targeted therapy: Treating cancer with specificity Hit paper breakdown → | 2018 | 800 |
| 2 | 2010 | 331 | |
| 3 | 2011 | 188 | |
| 4 | 2019 | 180 | |
| 5 | Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine Hit paper breakdown → | 2022 | 164 |
| 6 | 2015 | 86 | |
| 7 | 2015 | 68 | |
| 8 | 2018 | 63 | |
| 9 | 2015 | 63 | |
| 10 | 2016 | 54 | |
| 11 | 2011 | 49 | |
| 12 | 2018 | 43 | |
| 13 | 2020 | 42 | |
| 14 | 2015 | 39 | |
| 15 | 2016 | 39 | |
| 16 | 2014 | 38 | |
| 17 | 2020 | 37 | |
| 18 | 2019 | 35 | |
| 19 | 2017 | 34 | |
| 20 | 2018 | 33 |
About Chern Ein Oon
Chern Ein Oon is a scholar working on Molecular Biology, Plant Science, Epidemiology, Cancer Research and Oncology, having authored 70 papers that have together received 2.9k indexed citations. Recurring topics across this work include Bioactive Compounds in Plants (7 papers), Sirtuins and Resveratrol in Medicine (7 papers), Histone Deacetylase Inhibitors Research (7 papers), Cervical Cancer and HPV Research (6 papers), Gut microbiota and health (6 papers), Angiogenesis and VEGF in Cancer (6 papers), Cancer-related Molecular Pathways (5 papers) and Reproductive tract infections research (5 papers). The work is most often cited by research in Cancer Research (583 citations), Geriatrics and Gerontology (80 citations), Molecular Biology (1.4k citations), Oncology (473 citations) and Applied Microbiology and Biotechnology (27 citations). Chern Ein Oon has collaborated with scholars based in Malaysia, Australia and United Kingdom. Frequent co-authors include Yi Jer Tan, Yeuan Ting Lee, Adrian L. Harris, Gurjeet Kaur, Amin Malik Shah Abdul Majid, Venugopal Balakrishnan, Jiliang Li, Helen Turley, Russell Leek and Helen Sheldon. Their work appears in journals such as Life Sciences, Biomedicine & Pharmacotherapy, European Journal of Pharmacology, Microvascular Research and Drug and Chemical Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.